Skip to main content
Erschienen in: BMC Oral Health 1/2011

Open Access 01.12.2011 | Technical advance

A new portable monitor for measuring odorous compounds in oral, exhaled and nasal air

verfasst von: Naofumi Tamaki, Kenta Kasuyama, Mitsue Esaki, Takara Toshikawa, Shun-Ichi Honda, Daisuke Ekuni, Takaaki Tomofuji, Manabu Morita

Erschienen in: BMC Oral Health | Ausgabe 1/2011

Abstract

Background

The B/B Checker®, a new portable device for detecting odorous compounds in oral, exhaled, and nasal air, is now available. As a single unit, this device is capable of detecting several kinds of gases mixed with volatile sulfur compounds (VSC) in addition to other odorous gasses. The purpose of the present study was to evaluate the effectiveness of the B/B Checker® for detecting the malodor level of oral, exhaled, and nasal air.

Methods

A total of 30 healthy, non-smoking volunteers (16 males and 14 females) participated in this study. The malodor levels in oral, exhaled, and nasal air were measured using the B/B Checker® and by organoleptic test (OT) scores. The VSCs in each air were also measured by gas chromatography (GC). Associations among B/B Checker® measurements, OT scores and VSC levels were analyzed using Spearman correlation coefficients. In order to determine the appropriate B/B Checker® level for screening subjects with malodor, sensitivity and specificity were calculated using OT scores as an identifier for diagnosing oral malodor.

Results

In oral and nasal air, the total VSC levels measured by GC significantly correlated to that measured by the B/B Checker®. Significant correlation was observed between the results of OT scores and the B/B Checker® measurements in oral (r = 0.892, p < 0.001), exhaled (r = 0.748, p < 0.001) and nasal air (r = 0.534, p < 0.001). The correlation between the OT scores and VSC levels was significant only for oral air (r = 0.790, p < 0.001) and nasal air (r = 0.431, p = 0.002); not for exhaled air (r = 0.310, p = 0.096). When the screening level of the B/B Checker® was set to 50.0 for oral air, the sensitivity and specificity were 1.00 and 0.90, respectively. On the other hand, the screening level of the B/B Checker® was set to 60.0 for exhaled air, the sensitivity and specificity were 0.82 and 1.00, respectively.

Conclusion

The B/B Checker® is useful for objective evaluation of malodor in oral, exhaled and nasal air and for screening subjects with halitosis.

Trial registration

ClinicalTrials.gov: NCT01139073
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1472-6831-11-15) contains supplementary material, which is available to authorized users.

Competing interests

One of the author (T. Toshikawa) is employees of Taiyo Instrument Inc., which has been involved in the B/B Checker® development.

Authors' contributions

NT has made substantial contribution to the study conception and design. KK, ME, TT1, DE, and SH implemented this study and participated in the acquisition, analysis and interpretation of data. TT3 gave technical advices using the B/B Checker®. MM has been intimately involved in drafting and editing the manuscript. All authors read and approved the final manuscript.

Background

Halitosis affects a large proportion of the global population and may be the cause of a significant social or psychological handicap [1]. The number of subjects who visit dental clinics complaining of halitosis has been increasing, and it is estimated that more than 50% of the population in North America suffer from halitosis [2, 3]. An epidemiological survey of the general population of Japan showed that 24% of the individuals examined complained about bad breath [4].
Much emphasis has been reported in the literature regarding unpleasant odors in the oral cavity. Volatile sulfur compounds (VSCs) generated by oral bacteria are the major causes of halitosis and are major components of intra-oral odors [5, 6]. On the other hand, nasal passages predominate among extra-oral etiologies of bad breath. Nasal malodor is indicative of a nasal infection, such as sinusitis, tonsillitis, and rhinitis [7]. It has also been reported that patients with cleft lip and/or palate have a greater tendency to present nasal malodor compared to those without cleft lip and/or palate [8]. Moreover, odorous gases emanating form the pharyngeal or bronchial region contaminate exhaled air from the lungs [9]. Therefore, in order to manage patients with halitosis, an accurate and objective instrument for measuring malodor level in oral, exhaled, and nasal air is required. To date, however, only a few effective instruments like the halimeter exist that are capable of measuring malodor level originating from oral, exhaled and nasal air [7].
Currently, gas chromatography (GC) for determining the concentrations of VSCs is considered to be the most reliable method for measuring oral malodor [10]. Unfortunately, since GC is not suitable in daily clinical practice because of its complexity, simpler devices for detecting VSCs have been developed and are widely used [1113]. Actual biological gas, however, contains several odorous compounds other than VSCs, such as n-dodecanol, phenol, indole, and diamine [14, 15]. Indeed, it is commonly observed that VSC levels do not always correspond to actual odor levels perceived by humans. Therefore, organoleptic measurement, the subjective measurement of halitosis, is considered to be the most reliable, due to the fact that the human sense of smell can simultaneously detect several kinds of compounds, including VSCs and other odorous gases [3, 16].
Recently, the B/B Checker®, a new portable gas detector for measuring the malodor level from human oral, exhaled, and nasal air has been developed. As a single unit, this device is capable of detection of several kinds of gases, and also measuring of the malodor level in oral, exhaled, and nasal gases independently in a short period of time. The purpose of the present study was to examine the effectiveness of this new device in measuring malodor level in oral, exhaled and nasal air.

Methods

Subjects

A total of 30 periodontal healthy, non-smoking volunteers (16 males and 14 females, mean age: 43.9 ± 18.5 years) without medical disorders, and not undergoing any antibiotic or other antimicrobial therapy participated in the present study.

Measurement of malodor compounds

The following three gases from different origins were measured to determine malodor level: oral gas, which stagnates in the oral cavity (mouth air); exhaled gas, which passes through the oral cavity from the lungs following expiration (exhaled air); and nasal gas, which is expelled through the nasal cavity when the mouth is closed (nasal air). To determine genuine malodor level, the subjects were advised to abstain from food or drink on the morning of the assessment day and to refrain from their usual oral hygiene practice the morning of the day of the measurements. Subjects were also instructed to refrain from eating strong smelling foods for at least 48 h, using strong perfumes for 24 h, and drinking alcohol for 12 h prior to the measurements. Actual measurements were conducted in the morning, between 11:00 and 12:00. Subjects kept their mouths closed for 3 min prior to the measurement of oral malodor [13]. Before measuring exhaled and nasal air, subjects were instructed to keep their mouths open and breathe through the mouth for 30 sec.

B/B Checker® measurement

A thin-coat tin dioxide semiconductor gas sensor, that is sensitive to reductive gases, has been developed by Taiyo Instrument Inc., Osaka, Japan, and comprises a sensor probe and a main body equipped with a printer (Figure 1A). The sensor will detect various gasses, such as VSCs, hydrogen, ethanol, acetone, butylate, and ammonia. The B/B Checker® expresses the gas level (B/B Value) as the olfactory intensity of human according to the Weber-Fechner law. The gas level as the olfactory intensity was outputted as a single value (Range 0-100). The Weber-Fechner law states that the magnitude of a subjective sensation increases proportional to the logarithm of the stimulus intensity. In this case, I = k*logC, where I (B/B value) is the magnitudes of the perceived intensity of the stimuli (odor) and C is the magnitude of stimuli (concentration of odorous compounds).
The sensor probe covered with disposable adaptor was inserted directly into the mouth to prevent the loss of sample gas (Figure 1B). The cover prevents the direct contact of oral mucosa to sensor probe. Thus, there is little interference with gases in the oral cavity from surrounding gases during the measurement procedure and the sensor is capable of directly determining the gas levels without any interposition. Before oral air analysis, subjects were instructed to keep their mouths closed and to breathe through the nose for 180 sec. The sensor was inserted into the center of the oral cavity. Oral air was measured for 15 sec.
At the measurement of exhaled breath, the subjects were at first asked to expel oral air. The subjects breathed a deep inspiration, held their breath for 15 sec, and then tried to exhale breath from the lungs completely through the adapter over 15 sec. The B/B Checker® is capable of measuring maximum odorous gas levels in the terminal lung gas.
The sensor probe was then inserted into the nose adapter to measure nasal air. The malodor level in air from the right and left nasal cavity was analyzed separately. To measure the malodor level from one nasal cavity, the subjects compressed the opposite nostril with a finger. (Figure 1C).

Gas chromatography analysis

The GC analysis was conducted using a GC-14B gas chromatograph (Shimadzu Co., Kyoto, Japan), equipped with a flame photometric detector. After subjects kept their mouths closed for 3 min, a Teflon® tube connected to a glass syringe was inserted into the center of the oral cavity through the lips and teeth, while the lips remained closed. When measuring the malodor level of exhaled air, the gas samples were first collected in a Gas Pack, and a Teflon® tube was used for aspiration. Measurement of nasal air malodor was performed by inserting the Teflon® tube connected to a glass syringe approximately 1 cm into each nostril [17]. Following aspiration of 10 ml of oral, exhaled and nasal air, a 5 ml sample of air was transferred to the Shimalite® TPA column and gas chromatograph. The VSCs, hydrogen sulfide, methyl mercaptan, and dimethyl sulfide were determined by their characteristic retention time and were quantified via comparison of their peak area with that of dilutions of standards [18].

Organoleptic test

For the organoleptic test (OT), subjects were asked to exhale the gas through their mouth or nose briefly with moderate force at a distance of approximately 10 cm from the examiner. The malodor level in mouth and nasal air was subsequently assessed. When measuring the malodor level of exhaled air, the gas collected in the Gas Pack for GC analysis was assessed. The organoleptic measurement was performed by two trained dentists (KK, ME). These examiners rated the malodor on a 0-5 scale according to the procedures outlined in a previous report [19, 20]. Briefly, a score of 0 represented the absence of malodor, 1 barely noticeable malodor, 2 slight malodor, 3 moderate malodor, 4 strong malodor, and 5 extremely strong malodor. Examiners were blind to both the B/B Checker® measurements and GC analyses. The inter-examiner correlation of oraganoleptic rating was 0.95 (p < 0.001).

Statistical analysis

Data analysis was done with the Statistical Package for Social Science (SPSS version 19, SPSS Japan, Tokyo, Japan). Kruskal Wallis test was used to investigate the differences of mean values of measurements among the gasses from different origins. The association among the B/B Checker® measurements, OT scores and GC analysis of VSC concentrations was analyzed using Spearman correlation coefficients. In order to determine the appropriate level of the B/B Checker® for screening subjects with malodor, sensitivity and specificity was calculated using OT scores (≥ 3) as an identifier for diagnosing oral malodor. The sample size was calculated using statistical software (nQuery Advisor, Statistical Solutions, Sangus, MA, USA) based on the differences in malodor parameters (Oral gas and Exhaled gas) between high (≥ 3) and low OT scores in our preliminary study. A sample size of 9 per group was required for detection of a significant difference in exhaled gas (80% power; two-sided 5% significance level).

Ethical approval and registration

The protocol was approved by the Institutional Review Board of the Ethics Committee of Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences (No.425). All subjects provided signed informed consent before entry into the study. The trial is registered with ClinicalTrials.gov protocol registration system, ID NCT01139073.

Results

The mean level ± standard deviation of each gas measured using different procedures are shown in Table 1. Since methyl mercaptan and dimethyl sulfide were not detected in most of subjects, the measurement using GC was expressed as hydrogen sulfide level and total concentration of VSCs. All measurement procedures determined that exhaled air was the most odorous, followed by oral air and nasal air. All odor levels, i.e., B/B Checker® measurements, OT scores, and GC analyses for nasal air were significantly lower than those for oral and exhaled air. There was no significant difference of malodor level between oral air and exhaled air.
Table 1
Malodor measurements in oral, exhaled and nasal air.
   
Gas Chromatography (ppb)
 
Organoleptic
score
B/B Checker
(B/B value)
Hydrogen sulfide
Total VSCs
Oral air (N = 30)
2.6 ± 1.1
55.5 ± 18.3
77.9 ± 43.3
86.9 ± 47.6
Exhaled air (N = 30)
2.8 ± 1.0
61.4 ± 16.1
99.8 ± 65.8
106.4 ± 63.6
Nasal air (N = 60#)
1.3 ± 0.9*
41.0 ± 18.1*
46.9 ± 24.6*
49.1 ± 24.5*
Mean ± Standard deviation
# Right and left nasal air was measured individually
* Significantly lower than oral and exhaled air, p < 0.001
The correlation between the B/B Checker® measurements and total concentration of VSCs is shown in Figure 2. In oral and nasal air, total concentration of VSCs measured by GC significantly correlated to the malodor level detected using the B/B Checker®. However, there was no significant relationship between the two measurements in exhaled air.
Since the organoleptic scoring method is still considered to be the gold standard for determining oral malodor, the correlation coefficients of OT scores with the B/B Checker® and total concentration of VSCs measured by GC was calculated (Table 2). In all three types of air, a significant correlation was observed between the OT scores and B/B Checker® measurements (oral air: 0.892, p < 0.001; exhaled air: 0.748, p < 0.001; and nasal air: 0.534, p < 0.001). On the other hand, the correlation between the OT scores and total concentration of VSCs was significant only for oral air (0.790, p < 0.001) or nasal air (0.431, p = 0.002); not for exhaled (0.310, p = 0.096).
Table 2
Correlation coefficients of organoleptic ratings with the B/B Checker measurements and total VSCs measured by GC.
 
Correlation coefficients of organoleptic ratings with
 
B/B Checker
total VSCs by GC
Oral air
0.892***
0.790***
Exhaled air
0.748***
0.310
Nasal air
0.534***
0.431**
**: p < 0.01, ***: p < 0.001
As shown in Table 1 the value of malodor level was relatively low. In order to examine the usability of B/B Checker® in halitosis patients, those with OT scores (≥ 3) were selected (n = 20). In oral air, a significant correlation was observed between concentration of hydrogen sulfide and B/B Checker® measurements (0.790, p < 0.001).
The appropriate level of the B/B Checker® for screening subjects with malodor was determined by calculating sensitivity and specificity. The subjects with OT scores (≥ 3) were defined as those with clearly noticeable malodor (Figure 3). When the screening level of the B/B Checker® was set to 50 for oral air, the sensitivity and specificity was 1.00 and 0.90, respectively. On the other hand, when the screening level of the B/B Checker® was set to 60 for exhaled air, the sensitivity and specificity was 0.82 and 1.00, respectively. Since there were few subjects with OT scores (≥ 3) in nasal air, this particular analysis was not performed.

Discussion

The correlation coefficients of OT scores with the B/B Checker® measurements were significant for the oral, exhaled, and nasal air. It is now commonly accepted that the organoleptic scoring method is a gold standard for the study of malodor. Moreover, the B/B Checker® has relatively high sensitivity and specificity for screening subjects with noticeable malodor. Ueno et al. (2008) developed a new portable sulfide monitor, and reported that sensitivity is 0.8-0.9 and specificity is 0.6-0.8 [12]. The study by Ueno et al. employed 475 subjects, whereas only 30 participated in the present study. Although the high sensitivity (0.82-1.00) and specificity (0.90-1.00) of the B/B Checker® must be re-evaluated in a larger population, it may be useful for objective evaluation of malodor in oral, exhaled and nasal air and for screening subjects with halitosis.
Significant association between OT scores and total concentration of VSCs by GC was observed only for oral air, and not for exhaled or nasal air. On the other hand, OT scores and B/B Checker® measurements were significantly correlated for three kinds of air. In addition, there was no significant association between the total concentration of VSCs and B/B Checker® measurements in exhaled air. While the reason remains unclear, the GC focuses only on VSCs; hydrogen sulfide, methyl mercaptan and dimethyl sulfide. Therefore, some of the major components of oral air are VSCs, substances that both the B/B Checker® and GC are capable of detecting. It is likely that exhaled air, probably or nasal air, contain other major components that both the B/B Checker® and human nose, and not GC, could detect. In fact, it has been hypothesized that indole, skatole, putrescine, and cadaverine, and some organic acids, like acetic and butyric acid, also contribute to malodor [15]. Recently, Van den Velde et al. (2009) reported that di- and trimethyl sulfide are associated with malodor [21]. Based on these findings, devices sensitive to several kinds of gasses are required for malodor study.
Tangeman and Winkel (2007) proposed to clearly differentiate the origin of halitosis, intra- and extra-orally. The most predominant sources of halitosis (80-90%) are present within the oral cavity and include bacterial reservoirs such as the dorsum of the tongue, saliva and periodontal pockets [22]. This corresponds to the malodor in oral air in the present study. However, less attention has been paid to extra-oral halitosis [2224]. One of the origins of extra-oral halitosis is malodor in nasal air, which is considered to be related to serious systemic disease. Furthermore, we suspected that the air that passes through the oral cavity from the lung after expiring oral air that has stagnated in the oral cavity might be another origin of extra-oral halitosis. As a result, all three kinds of measurements, i.e., B/B Checker® measurements, total concentration of VSCs, and OT scores, showed that the malodor level was greatest in the exhaled air, followed by oral air and nasal air. Since healthy subjects, without any medical disorders, were employed in the present study, the lowest scores in the nasal air were deemed reasonable. Moreover, the present study indicates that future studies should focus on exhaled air for halitosis management.
Many articles have discussed the generation of bad breath in the oral cavity. However, to date, few devices have been developed for effectively measuring malodor in nasal or exhaled air and few studies of nasal malodor and its causes have been published [17]. It has been reported that patients with cleft lip and/or palate have a greater tendency to present higher nasal VSC measurements, indicating the usefulness of VSC measurements for evaluation of quality of life (QOL) in these patients. The B/B Checker® has a special adaptor for the nasal cavity, allowing the sensor to be placed directly into the nasal cavity without gas contamination. Accurate assessment and testing are important to determine which point is an actual problem. Therefore, the B/B Checker® is applicable for QOL determination for cleft patients. The present study also examined the ability of conducting measurements of exhaled air in a clinical situation. Moreover, the B/B Checker® showed adequate sensitivity for detecting malodor and a fair specificity for identifying non-malodor cases. The results of the present study suggest that the B/B Checker® could be used as an adjunct instrument to a GC system and organoleptic methods currently in use at clinical situation for determining malodor in oral, exhaled and nasal air.
The malodor levels of exhaled air were higher than of oral air, however, no significant differences were observed in the levels of OT score, B/B value, hydrogen sulfide and VSCs. The sources of hydrogen sulfide may be multiple, including the bacterial flora [25], as well as endogenous sulfide-generating enzymes that exist in many cells and tissues of the human body [26]. Oral air was thought to be relatively low in subjects at the present study because periodontally healthy subjects were analyzed. If we have measured in malodor levels at periodontal patients, oral air would be higher than exhaled breath.
This study has some limitations. At first, the subjects who participated in the present study had relatively mild halitosis. The mean VSC levels ranged from 40 to 110 ppb of the total concentration of VSCs. It remains unclear whether the B/B Checker® measurements correlate to GC or organoleptic ratings in subjects with severe halitosis. Since it is apparent that VSCs cause severe halitosis and that the B/B Checker® is capable of detecting several gases, the B/B Checker® might be less sensitive to severely malodorous air in 5 subjects complaining of oral malodor. Secondly, the present study is only a cross sectional study. Therefore, the effect of malodor management in clinic should be monitored using the B/B Checker®. Then, the usefulness of this device can be actually provided.

Conclusion

The results from the present study show that the correlation coefficients of OT scores with measurements from the B/B Checker® were significant for oral, exhaled and nasal air. In oral and nasal air, the total concentration of VSCs measured by GC significantly correlated to the malodor level determined using the B/B Checker®. The B/B Checker® may be effective for objective evaluation of malodor in oral, exhaled and nasal air and for screening subjects with halitosis in the clinical setting. Further clinical studies are needed to investigate the capability of measuring the malodor of each type of air (i.e., oral, exhaled, nasal) in different sample groups with systemic disease or periodontal disease.
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://​creativecommons.​org/​licenses/​by/​2.​0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

One of the author (T. Toshikawa) is employees of Taiyo Instrument Inc., which has been involved in the B/B Checker® development.

Authors' contributions

NT has made substantial contribution to the study conception and design. KK, ME, TT1, DE, and SH implemented this study and participated in the acquisition, analysis and interpretation of data. TT3 gave technical advices using the B/B Checker®. MM has been intimately involved in drafting and editing the manuscript. All authors read and approved the final manuscript.
Anhänge

Authors’ original submitted files for images

Literatur
2.
Zurück zum Zitat Tessier JF, Kulkarni GV: Bad breath: etiology, diagnosis and treatment. Oral Health. 1991, 81: 19-22.PubMed Tessier JF, Kulkarni GV: Bad breath: etiology, diagnosis and treatment. Oral Health. 1991, 81: 19-22.PubMed
3.
Zurück zum Zitat Bosy A: Oral malodor: philosophical and practical aspects. J Can Dent Assoc. 1997, 63: 196-201.PubMed Bosy A: Oral malodor: philosophical and practical aspects. J Can Dent Assoc. 1997, 63: 196-201.PubMed
4.
Zurück zum Zitat Miyazaki H, Sakao S, Katoh Y, Takehara T: Oral malodor in the general population of Japan. Bad breath: research perspectives. 1995, Tel Aviv: Ramot Publishing, 119-136. Miyazaki H, Sakao S, Katoh Y, Takehara T: Oral malodor in the general population of Japan. Bad breath: research perspectives. 1995, Tel Aviv: Ramot Publishing, 119-136.
5.
Zurück zum Zitat Tonzetich J, Richter VJ: Evaluation of volatile odoriferous components of saliva. Arch Oral Biol. 1964, 9: 39-45. 10.1016/0003-9969(64)90042-1.CrossRefPubMed Tonzetich J, Richter VJ: Evaluation of volatile odoriferous components of saliva. Arch Oral Biol. 1964, 9: 39-45. 10.1016/0003-9969(64)90042-1.CrossRefPubMed
6.
Zurück zum Zitat Tonzetich J: Direct gas chromatographic analysis of sulphur compounds in mouth air in man. Arch Oral Biol. 1971, 16: 587-597. 10.1016/0003-9969(71)90062-8.CrossRefPubMed Tonzetich J: Direct gas chromatographic analysis of sulphur compounds in mouth air in man. Arch Oral Biol. 1971, 16: 587-597. 10.1016/0003-9969(71)90062-8.CrossRefPubMed
7.
Zurück zum Zitat Rosenberg M: Clinical assessment of bad breath: current concepts. J Am Dent Assoc. 1996, 127: 475-482.CrossRefPubMed Rosenberg M: Clinical assessment of bad breath: current concepts. J Am Dent Assoc. 1996, 127: 475-482.CrossRefPubMed
8.
Zurück zum Zitat Monteiro-Amado F, Montenegro Chinellato LE, Tárzia O, Rubo de Rezende ML: Evaluation of oral and nasal odor in patients with and without cleft lip and palate: preliminary report. Cleft Palate Craniofac J. 2004, 41: 661-663. 10.1597/02-163.1.CrossRefPubMed Monteiro-Amado F, Montenegro Chinellato LE, Tárzia O, Rubo de Rezende ML: Evaluation of oral and nasal odor in patients with and without cleft lip and palate: preliminary report. Cleft Palate Craniofac J. 2004, 41: 661-663. 10.1597/02-163.1.CrossRefPubMed
10.
Zurück zum Zitat Tonzetich J, Coil JM, Ng W: Gas chromatographic method for trapping and detection of volatile organic compounds from human mouth air. J Clin Dent. 1991, 2: 79-82.PubMed Tonzetich J, Coil JM, Ng W: Gas chromatographic method for trapping and detection of volatile organic compounds from human mouth air. J Clin Dent. 1991, 2: 79-82.PubMed
11.
Zurück zum Zitat Rosenberg M, Kulkarni GV, Bosy A, McCulloch CAG: Reproducibility and sensitivity of oral malodor measurements with a portable sulfide monitor. J Dent Res. 1991, 70: 1436-1440. 10.1177/00220345910700110801.CrossRefPubMed Rosenberg M, Kulkarni GV, Bosy A, McCulloch CAG: Reproducibility and sensitivity of oral malodor measurements with a portable sulfide monitor. J Dent Res. 1991, 70: 1436-1440. 10.1177/00220345910700110801.CrossRefPubMed
12.
Zurück zum Zitat Ueno M, Shinada K, Yanagisawa T, Mori C, Yokoyama S, Furukawa S, Takehara S, Kawaguchi Y: Clinical oral malodor measurement with a portable sulfide monitor. Oral Dis. 2008, 14: 264-269. 10.1111/j.1601-0825.2007.01374.x.CrossRefPubMed Ueno M, Shinada K, Yanagisawa T, Mori C, Yokoyama S, Furukawa S, Takehara S, Kawaguchi Y: Clinical oral malodor measurement with a portable sulfide monitor. Oral Dis. 2008, 14: 264-269. 10.1111/j.1601-0825.2007.01374.x.CrossRefPubMed
13.
Zurück zum Zitat Murata T, Rahardjo A, Fujiyama Y, Yamaga T, Hanada M, Yaegaki K, Miyazaki H: Development of a compact and simple gas chromatography for oral malodor measurement. J Periodontol. 2006, 77: 1142-1147. 10.1902/jop.2006.050388.CrossRefPubMed Murata T, Rahardjo A, Fujiyama Y, Yamaga T, Hanada M, Yaegaki K, Miyazaki H: Development of a compact and simple gas chromatography for oral malodor measurement. J Periodontol. 2006, 77: 1142-1147. 10.1902/jop.2006.050388.CrossRefPubMed
14.
Zurück zum Zitat Kostelc JG, Preti G, Zelson PR, Brauner L, Baehni P: Oral odors in early experimental gingivitis. J Periodont Res. 1984, 19: 303-312. 10.1111/j.1600-0765.1984.tb00821.x.CrossRefPubMed Kostelc JG, Preti G, Zelson PR, Brauner L, Baehni P: Oral odors in early experimental gingivitis. J Periodont Res. 1984, 19: 303-312. 10.1111/j.1600-0765.1984.tb00821.x.CrossRefPubMed
15.
Zurück zum Zitat Goldberg S, Kozlovsky A, Gordon D, Gelernter I, Sintov A, Rosenberg M: Cadaverine as a putative component of oral malodor. J Dent Res. 1994, 73: 1168-1172.PubMed Goldberg S, Kozlovsky A, Gordon D, Gelernter I, Sintov A, Rosenberg M: Cadaverine as a putative component of oral malodor. J Dent Res. 1994, 73: 1168-1172.PubMed
16.
Zurück zum Zitat Rosenberg M, McCulloch CA: Measurement of oral malodor: current methods and future prospects. J Periodontol. 1992, 63: 776-782.CrossRefPubMed Rosenberg M, McCulloch CA: Measurement of oral malodor: current methods and future prospects. J Periodontol. 1992, 63: 776-782.CrossRefPubMed
17.
Zurück zum Zitat Doruk C, Oztürk F, Ozdemir H, Nalçaci R: Oral and nasal malodor in patients with and without cleft lip and palate who had undergone orthodontic therapy. Cleft Palate Craniofac J. 2008, 45: 481-484. 10.1597/07-074.1.CrossRefPubMed Doruk C, Oztürk F, Ozdemir H, Nalçaci R: Oral and nasal malodor in patients with and without cleft lip and palate who had undergone orthodontic therapy. Cleft Palate Craniofac J. 2008, 45: 481-484. 10.1597/07-074.1.CrossRefPubMed
18.
Zurück zum Zitat Shinada K, Ueno M, Konishi C, Takehara S, Yokoyama S, Kawaguchi Y: A randomized double blind crossover placebo-controlled clinical trial to assess the effects of a mouthwash containing chlorine dioxide on oral malodor. Trials. 2008, 9: 71-10.1186/1745-6215-9-71.CrossRefPubMedPubMedCentral Shinada K, Ueno M, Konishi C, Takehara S, Yokoyama S, Kawaguchi Y: A randomized double blind crossover placebo-controlled clinical trial to assess the effects of a mouthwash containing chlorine dioxide on oral malodor. Trials. 2008, 9: 71-10.1186/1745-6215-9-71.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Shinada K, Ueno M, Konishi C, Takehara S, Yokoyama S, Zaitsu T, Ohnuki M, Wright F, Kawaguchi Y: Effects of a mouthwash with chlorine dioxide on oral malodor and salivary bacteria: a randomized placebo-controlled 7-day trial. Trials. 2010, 11: 14-10.1186/1745-6215-11-14.CrossRefPubMedPubMedCentral Shinada K, Ueno M, Konishi C, Takehara S, Yokoyama S, Zaitsu T, Ohnuki M, Wright F, Kawaguchi Y: Effects of a mouthwash with chlorine dioxide on oral malodor and salivary bacteria: a randomized placebo-controlled 7-day trial. Trials. 2010, 11: 14-10.1186/1745-6215-11-14.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Morita M, Wang HL: Relationship between sulcular sulfide level and oral malodor in subjects with periodontal disease. J Periodontol. 2001, 72: 79-84. 10.1902/jop.2001.72.1.79.CrossRefPubMed Morita M, Wang HL: Relationship between sulcular sulfide level and oral malodor in subjects with periodontal disease. J Periodontol. 2001, 72: 79-84. 10.1902/jop.2001.72.1.79.CrossRefPubMed
21.
Zurück zum Zitat Van den Velde S, van Steenberghe D, Van hee P, Quirynen M: Detection of Odorous Compounds in Breath. J Dent Res. 2009, 88: 285-289.CrossRefPubMed Van den Velde S, van Steenberghe D, Van hee P, Quirynen M: Detection of Odorous Compounds in Breath. J Dent Res. 2009, 88: 285-289.CrossRefPubMed
22.
Zurück zum Zitat Tangeman A, Winkel EG: Intra- and extra-oral halitosis: finding of a new form of extra-oral blood-borne halitosis caused by dimethyl sulfide. J Clin Periodontol. 2007, 34: 748-755. 10.1111/j.1600-051X.2007.01116.x.CrossRef Tangeman A, Winkel EG: Intra- and extra-oral halitosis: finding of a new form of extra-oral blood-borne halitosis caused by dimethyl sulfide. J Clin Periodontol. 2007, 34: 748-755. 10.1111/j.1600-051X.2007.01116.x.CrossRef
23.
Zurück zum Zitat Monteiro-Amado F, Chinellato LE, de Rezende ML: Evaluation of oral and nasal halitosis parameters in patients with repaired cleft lip and/or palate. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005, 100: 682-687. 10.1016/j.tripleo.2005.03.019.CrossRefPubMed Monteiro-Amado F, Chinellato LE, de Rezende ML: Evaluation of oral and nasal halitosis parameters in patients with repaired cleft lip and/or palate. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005, 100: 682-687. 10.1016/j.tripleo.2005.03.019.CrossRefPubMed
24.
Zurück zum Zitat Monteiro-Amado F, Montenegro Chinellato LE, Tárzia O, de Rezende ML: Evaluation of oral and nasal odor in patients with and without cleft lip and palate: preliminary report. Cleft Palate Craniofac J. 2004, 41: 661-663. 10.1597/02-163.1.CrossRefPubMed Monteiro-Amado F, Montenegro Chinellato LE, Tárzia O, de Rezende ML: Evaluation of oral and nasal odor in patients with and without cleft lip and palate: preliminary report. Cleft Palate Craniofac J. 2004, 41: 661-663. 10.1597/02-163.1.CrossRefPubMed
25.
Zurück zum Zitat Scully C, Greenman J: Halitosis (breath odor). Periodontology 2000. 2008, 48: 66-75. 10.1111/j.1600-0757.2008.00266.x.CrossRefPubMed Scully C, Greenman J: Halitosis (breath odor). Periodontology 2000. 2008, 48: 66-75. 10.1111/j.1600-0757.2008.00266.x.CrossRefPubMed
26.
Zurück zum Zitat Studer SM, Orens JB, Krishnan JA, Cope KA, Yang S, Conte JV, Becker PB, Risby TH: Patterns and significance of exhaled-breath biomarkers in lung transplant recipients with acute allograft rejection. J Heart Lung Transplant. 2001, 20: 1158-1166. 10.1016/S1053-2498(01)00343-6.CrossRefPubMed Studer SM, Orens JB, Krishnan JA, Cope KA, Yang S, Conte JV, Becker PB, Risby TH: Patterns and significance of exhaled-breath biomarkers in lung transplant recipients with acute allograft rejection. J Heart Lung Transplant. 2001, 20: 1158-1166. 10.1016/S1053-2498(01)00343-6.CrossRefPubMed
Metadaten
Titel
A new portable monitor for measuring odorous compounds in oral, exhaled and nasal air
verfasst von
Naofumi Tamaki
Kenta Kasuyama
Mitsue Esaki
Takara Toshikawa
Shun-Ichi Honda
Daisuke Ekuni
Takaaki Tomofuji
Manabu Morita
Publikationsdatum
01.12.2011
Verlag
BioMed Central
Erschienen in
BMC Oral Health / Ausgabe 1/2011
Elektronische ISSN: 1472-6831
DOI
https://doi.org/10.1186/1472-6831-11-15

Weitere Artikel der Ausgabe 1/2011

BMC Oral Health 1/2011 Zur Ausgabe

Parodontalbehandlung verbessert Prognose bei Katheterablation

19.04.2024 Vorhofflimmern Nachrichten

Werden Personen mit Vorhofflimmern in der Blanking-Periode nach einer Katheterablation gegen eine bestehende Parodontitis behandelt, verbessert dies die Erfolgsaussichten. Dafür sprechen die Resultate einer prospektiven Untersuchung.

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

11.04.2024 Endokarditis Nachrichten

Bei welchen Personen eine Antibiotikaprophylaxe zur Prävention einer infektiösen Endokarditis nach invasiven zahnärztlichen Eingriffen sinnvoll ist, wird diskutiert. Neue Daten stehen im Einklang mit den europäischen Leitlinienempfehlungen.

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

08.04.2024 Zahnmedizin Nachrichten

Der Aufbau von Geweben und Organen während der Embryonalentwicklung wird von den Zellen bemerkenswert choreografiert. Für diesen Prozess braucht es spezielle sogenannte „Organisatoren“. In einer aktuellen Veröffentlichung im Fachjournal Nature Cell Biology berichten Forschende durch welchen Vorgang diese Organisatoren im Gewebe entstehen und wie sie dann die Bildung von Zähnen orchestrieren.

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

11.03.2024 Kinderzahnmedizin Nachrichten

Infolge der Umbenennung der Deutschen Gesellschaft für Kinderzahnheilkunde in Deutsche Gesellschaft für Kinderzahnmedizin (DGKiZ) wird deren Mitgliederzeitschrift Oralprophylaxe & Kinderzahnheilkunde in Oralprophylaxe & Kinderzahnmedizin umbenannt. Aus diesem Grunde trägt die erste Ausgabe in 2024 erstmalig den neuen Titel.

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.